Industry NewsAI Business & Ecosystem
Neko Health Raises $700 Million Series C to Expand AI-Powered Preventive Healthcare Platform
Article content
Neko Health Accelerates Expansion with New Funding
Neko Health has raised $700 million in Series C funding, marking a significant milestone in its mission to reshape healthcare through AI-powered preventive medicine.
Founded by Hjalmar Nilsonne and Daniel Ek, the company is building a healthcare model centered on detecting health risks before they develop into disease. The latest investment will support continued product development, expansion into the United States, and broader access to preventive healthcare services.
The company plans to launch its first US clinic in New York City, marking its next phase of international growth.
Key Highlights
The funding supports Neko Health's long-term vision of making preventive healthcare more accessible and data-driven.
Highlights
- $700 million raised in Series C funding.
- Expansion into the United States, beginning with New York City.
- More than 100,000 people have completed the Neko Health Scan.
- Continued investment in AI-powered diagnostics, medical devices, software, and clinical infrastructure.
- Focus on earlier disease detection and personalized healthcare.
Reinventing Preventive Healthcare
Rather than focusing solely on treating illness after symptoms appear, Neko Health is building technology designed to identify subtle health changes before disease progresses.
The company's approach combines medical imaging, advanced sensors, artificial intelligence, software, clinical workflows, and physician-led assessments into a single preventive health platform.
Its flagship Neko Health Scan captures millions of health data points during a comprehensive 60-minute examination, enabling clinicians to provide detailed health insights during the same visit.
Leadership Perspective
Hjalmar Nilsonne, Founder and CEO, Neko Health
Hjalmar Nilsonne said the healthcare industry has made remarkable progress in treating disease, but the next major challenge is understanding health before medical conditions develop.
He explained that preventive healthcare requires continuous health monitoring supported by advances in diagnostics, AI, medical devices, and clinical workflows rather than incremental improvements to existing healthcare systems.
According to Nilsonne, the latest funding will accelerate the company's efforts to improve both the quality and affordability of preventive care while expanding access to earlier detection and more personalized health services.
Why This Matters
The investment reflects growing momentum behind AI-enabled preventive healthcare, where continuous health monitoring is becoming as important as treatment.
Industry Impact
- AI is enabling earlier detection of chronic diseases through continuous health analysis.
- Healthcare providers are investing in proactive care models rather than reactive treatment.
- Integrated platforms combining hardware, software, AI, and clinical expertise are emerging as the next generation of healthcare delivery.
- Personalized diagnostics continue to gain traction as healthcare systems seek to improve long-term patient outcomes while reducing treatment costs.
As healthcare organizations increasingly adopt AI across diagnostics and clinical decision-making, preventive care is becoming one of the sector's fastest-growing areas of innovation.
About Neko Health
Neko Health is a health technology company founded by Hjalmar Nilsonne and Daniel Ek. The company develops AI-powered preventive healthcare solutions that combine medical devices, imaging technology, software, sensors, and clinical expertise to identify health risks earlier and improve long-term patient outcomes.
Source and Credits
Source & Credits: Hjalmar Nilsonne, Founder & CEO, Neko Health, LinkedIn Announcement